<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>Could a Common Heartburn Drug Be a Coronavirus Treatment?</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2020/04/28/could-a-common-heartburn-drug-be-a-coronavirus-treatment.aspx</link><description>A new clinical trial using famotidine &amp;mdash; an ingredient in the over-the-counter drug Pepcid &amp;mdash; may help provide a treatment for COVID-19. Dr. Kevin Tracey, president of Feinstein Institutes for Medical Research at Northwell Health, has so far</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>